VERA
Vera Therapeutics, Inc. Class A Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Vera Therapeutics (VERA) Stock: Buy, Sell, or Hold?
$28.10
-0.94 (-3.24%)
âŧ
5d:
-5.66%
30d:
-1.65%
90d:
-11.16%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (37%)
Quality Score
39/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$28.31 â $30.88
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-7.2x
Next 12M consensus est.
Wall Street Target
$71.36
+153.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$27.85 / $32.78
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: VERA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 6, 2026 at $29.79 · last confirmed Nov 9, 2026
Strength: 4.7/10
Get Alerted When VERA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: VERA is currently trading at $28.10, which is considered slightly high relative to its 30-day fair value range of $28.31 to $30.88.
Technical Outlook: Technically, VERA is in a strong downtrend. The price is currently testing key support at $27.85. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: VERA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $71.36 (+153.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VERA is in a strong downtrend. The price is currently testing key support at $27.85. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: VERA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $71.36 (+153.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$28.31 -
$30.88
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
36.8%
Trading Range & Key Levels
30-Day Trading Range
$28.31 -
$30.88
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$27.85
Resistance Level
$32.78
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 153.9% below Wall St target ($71.36)
- WARNING: Composite score 39/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-7.18
Wall Street Target
$71.36
(+153.9%)
Share VERA Analysis
Share this live VERA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (VERA)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary:
Vera Therapeutics (VERA) reported Q3 loss that was smaller than estimated, with revenue surpassing expectations. The stock has underperformed the market this year.
Key Retail Themes:
Earnings beat
Revenue growth
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 14, 2026 11:51 PM ET
Data refreshes hourly during market hours. Next update: 12:51 AM
Data refreshes hourly during market hours. Next update: 12:51 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VERA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 52 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 49 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 31 SELL |
|
ARWR
Arrowhead PharmaceuticalâĻ |
STRONG BUY
15 analysts |
$108 | 50 HOLD |
|
ZYME
Zymeworks Inc. Common StâĻ |
STRONG BUY
14 analysts |
$42 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive VERA Research Pages
